Kršková Katarína, Dobrócsyová Viktória, Ferenczyová Kristína, Hricovíniová Jana, Kaločayová Barbora, Duľová Ulrika, Bozorgnia Mahdi, Barteková Monika, Zorad Štefan
Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská Cesta 9, Bratislava 4, 84505, Slovakia.
Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, 84104, Slovakia.
J Physiol Biochem. 2025 Feb;81(1):137-156. doi: 10.1007/s13105-024-01060-9. Epub 2024 Nov 22.
Reactive oxygen species (ROS) play a key role in the regulation of adipogenesis. The aim of our study was to investigate the effect of quercetin (QCT) supplement on obese adipose tissue metabolism of 30-week-old diabetic Zucker rats (ZDF), not well examined yet. QCT was administered orally at dose of 20 mg/kg body weight/day for 6 weeks. Adipocytes from subcutaneous adipose tissue (ScWAT) were isolated and their size was evaluated by light microscopy. Gene expression of adipogenic markers in subcutaneous and visceral adipose tissue was determined by real-time PCR and expression of proteins involved in lipid and glucose metabolism was determined in ScWAT by immunoblotting. Obese ZDF rats suffered from diabetes, hyperinsulinemia and had higher index HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Treatment with QCT had no significant impact on these metabolic disorders in genetic model of obesity and type 2 diabetes used in our study. Nevertheless, QCT reduced expression of inflammatory cytokine tumour necrosis factor alpha in ScWAT and also visceral adipose tissue and up-regulated expression of anti-inflammatory adiponectin in ScWAT. A shift in redox equilibrium was detected via inhibition of pro-oxidant genes by QCT. Furthermore, QCT reduced adipocyte size in ScWAT, down-regulated expression of fatty acid synthase and adipogenic markers, and moreover stimulated expression of proteolytic enzymes. These changes likely resulted in reduced fat deposition in ScWAT, which was reflected in the elevated circulated levels of free fatty acids in QCT-treated obese ZDF rats compared with obese untreated controls. This increase could, at least in part, explain why we did not observe an improvement in systemic metabolic health by QCT in our model. In conclusion, our study suggests that preventive treatment with QCT might be more effective than its administration in the stage of fully developed diabetes, and further research in this area is needed.
活性氧(ROS)在脂肪生成的调节中起关键作用。我们研究的目的是调查槲皮素(QCT)补充剂对30周龄糖尿病Zucker大鼠(ZDF)肥胖脂肪组织代谢的影响,目前对此研究较少。以20毫克/千克体重/天的剂量口服给予QCT,持续6周。分离皮下脂肪组织(ScWAT)中的脂肪细胞,并通过光学显微镜评估其大小。通过实时PCR测定皮下和内脏脂肪组织中脂肪生成标志物的基因表达,并通过免疫印迹法测定ScWAT中参与脂质和葡萄糖代谢的蛋白质表达。肥胖的ZDF大鼠患有糖尿病、高胰岛素血症,且胰岛素抵抗的稳态模型评估(HOMA-IR)指数较高。在我们研究中使用的肥胖和2型糖尿病遗传模型中,QCT治疗对这些代谢紊乱没有显著影响。然而,QCT降低了ScWAT以及内脏脂肪组织中炎性细胞因子肿瘤坏死因子α的表达,并上调了ScWAT中抗炎性脂联素的表达。通过QCT对促氧化基因的抑制检测到氧化还原平衡的转变。此外,QCT减小了ScWAT中脂肪细胞的大小,下调了脂肪酸合酶和脂肪生成标志物的表达,并且还刺激了蛋白水解酶的表达。这些变化可能导致ScWAT中脂肪沉积减少,这反映在与未治疗的肥胖对照相比,QCT治疗的肥胖ZDF大鼠循环中游离脂肪酸水平升高。这种升高至少可以部分解释为什么在我们的模型中未观察到QCT对全身代谢健康的改善。总之,我们的研究表明,在糖尿病完全发展阶段之前用QCT进行预防性治疗可能比给药更有效,并且该领域需要进一步研究。